Immunogenicity and safety of a recombinant tetravalent dengue vaccine in children and adolescents ages 9-16 years in Brazil. [electronic resource]
Producer: 20140226Description: 1058-1065 p. digitalISSN:- 1476-1645
- Adolescent
- Antibodies, Neutralizing -- blood
- Antibodies, Viral -- blood
- Brazil
- Child
- Cohort Studies
- Dengue -- immunology
- Dengue Vaccines -- administration & dosage
- Dengue Virus -- immunology
- Female
- Headache
- Humans
- Injections, Subcutaneous -- adverse effects
- Male
- Single-Blind Method
- Vaccination
- Vaccines, Synthetic -- administration & dosage
No physical items for this record
Publication Type: Clinical Trial, Phase II; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.